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Bachground: To assess the correlation of H. pylori infection with mitochondrial microsatellite instability (mtMSI) and
IL-8 in gastric carcinogenesis.
Methods: H. pylori infection was evaluated through histology and a urease breath test; mtMSI was measured using
PCR-single strand conformation polymorphism (PCR-SSCP); IL-8 was analyzed with ELISA methods.
Results: The detection rate of mtMSI was significantly higher in specimens with H. pylori infection than in those
without H. pylori infection (P < 0.05). The levels of IL-8 were significantly higher in specimens with mtMSI than in
those without mtMSI (P < 0.01).An association of mtMSI with the intestinal histological type was found (P < 0.05).
Increased IL-8 levels induced by H. pylori were related to the invasion, lymphnode spreading and clinical stage of
gastric cancer (P < 0.05).
Conclusions: H. pylori infection is related to mitochondrial microsatellite instability in the early steps of gastric
cancer development. IL-8 may play a role in the development of mtMSI induced by H. pylori. Our results support a
role for mtMSI in different mechanisms of gastric carcinogenesis.
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Gastric carcinogenesis is a complex multistep multi-
factorial event, in which the role of Helicobacter pylori
(H. pylori) infection, the major etiopathogenic factor
underlying chronic antral gastritis and duodenal ulcer,
has been established in recent years [1, 2]. Infection
with H. pylori, especially with CagA+ strains, has been
associated with an increased risk of noncardia gastric
adenocarcinoma [3, 4]. The epidemiological link be-
tween H. pylori and gastric carcinoma has been con-
firmed, and the rate of gastric carcinoma development
in the Japanese population with H. pylori-gastritis was
reported to be 2.9 % during a 7.8-year period [5]. The
mechanism by which H. pylori contributes to gastric
carcinogenesis is still largely unknown. The chronic
inflammatory reaction caused by the bacterium is* Correspondence: fangdianchun@hotmail.com
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potential to cause excess production of reactive oxy-
gen species and consequent mutagenic and carcino-
genic changes in DNA [6, 7]. ROS production has
been shown to occur in association with this bacter-
ium both in vitro and in vivo [8–10]. The dietary in-
take of antioxidants, measured as the total antioxidant
potential, is inversely associated with the risk of both
cardia and distal cancer [11].
H. pylori infection results in the induction of a number
of genes in host cells that are potential determinants of
inflammation. Interleukin-8 (IL-8), a CXC chemokine
specific for neutrophil granulocyte chemotaxis, is a cen-
tral mediator of the inflammatory response to H. pylori
and has been found to be involved in H. pylori-associ-
ated gastric carcinogenesis [12]. IL-8 induction in gastric
epithelial cells has been clearly correlated with a func-
tional cagA gene [13]. In H. pylori strains that express
CagA, cytokine expression has been linked to anle is distributed under the terms of the Creative Commons Attribution 4.0
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sion of IL-8 was found to be 10 times higher in gastric
cancer tissue than in normal tissue and to be two times
higher in advanced gastric cancer tissue than early
cancer tissue [15]. The eradication of H. pylori decreases
IL-8 expression significantly, suggesting that gastric can-
cer may be associated with the inflammatory process in
the gastric mucosa through the over-expression of IL-8
[16]. It is therefore expected that intervention with an
IL-8 inhibitor would inhibit or reverse the process of H.
pylori-related carcinogenesis.
Genetic instability plays a key role in neoplastic trans-
formation and progression [17, 18]. A previous study by
our group showed that in gastric carcinomas, such gen-
etic instability may be classified into two different forms,
in which hypermutability occurs by means of either
chromosomal instability or microsatellite instability
(MSI) [19, 20]. Although a wide spectrum of MSI alter-
ations in the nuclear DNA (nMSI) of cancer cells has
been established, little attention has been paid to MSI in
the mitochondrial DNA (mtMSI) of H. pylori-infected
gastric tissues. The mitochondrial genome is more vul-
nerable to oxidative damage and experiences a higher
rate of mutation than the nuclear genome [21]. The biol-
ogy of the mitochondrion suggests that its genome may
be an attractive target for ROS, which could drive
tumorigenesis. Tumor formation is often associated with
mtDNA mutations and alterations in mitochondrial gen-
ome function. Our previous studies have identified se-
quential accumulation of mtMSI in the histological
progression from chronic gastritis to gastric cancer, sug-
gesting that mtMSI may play an early and important role
in the gastric carcinogenesis pathway, especially in
intestinal-type cancer and distal gastric cancer [22].
However, the role of mtMSI following oxidative DNA
damage in H. pylori-related gastric carcinoma is less
clear. In the present study, we explored the associations
between H. pylori infection, mtMSI and IL-8 to elucidate
whether mtMSI triggers the progression from H. pylori-
gastritis to intestinal metaplasia and dysplasia and,
finally, to gastric cancer.
Methods
Tissue samples
A total of 122 fresh samples from surgically resected
gastric carcinomas and 100 fresh samples of endoscopic-
ally obtained non-neoplastic gastric mucosa (40 chronic
gastritis, 40 intestinal metaplasia and 20 dysplasia mu-
cosa) were studied. In addition, we collected 30 gastric
biopsies from patients without any gastric disease as a
control for the analysis of mtMSI and IL-8 alterations.
Hematoxylin-eosin (HE) staining was performed for
histopathological diagnosis and to evaluate gastritis, at-
rophy, intestinal metaplasia, dysplasia and cancer.Genomic DNA was isolated using standard proteinase K
digestion and phenol-chloroform extraction protocols.
No patient had received non-steroidal anti-inflammatory
drugs, proton pump inhibitors, or antibiotics within the
previous three months. None of the gastric cancer pa-
tients included in the present series had a family history
suggestive of HNPCC or had received chemotherapy or
radiation therapy. This study was approved by the
Bioethical Committee of the southwest hospital, and all
patients signed informed consent forms before inclusion.
Histology
The surgically resected and biopsy specimens were fixed
in 10 % buffered formalin, embedded in paraffin wax,
cut into sequential 4 μm sections, and subjected to
hematoxylin and eosin (H&E) and modified Giemsa
staining. In most cases, we cut three to five serial sec-
tions from each specimen, and multiple high power
fields were examined. Virtually all of the specimens in-
cluded the surface epithelium and muscularis mucosa.
The specimens were examined by one experienced hist-
ologist blinded to the patient’s clinical diagnosis and H.
pylori characteristics.
H. pylori assessment
The presence of H. pylori was determined through hist-
ology and a urease breath test. Patients were classified as
H. pylori-positive if at least one of the examinations pro-
duced a positive result.
IL-8 quantification
For IL-8 protein quantification, we used the same biopsy
specimens as were used for H. pylori detection. Biopsy
specimens were placed in 1.5 ml of PBS (pH 7.4) and were
immediately homogenized using a tissue homogenizer, as
described previously [23]. Aliquots of the homogenate
supernatant, obtained via centrifugation (10,000 g for
10 min), were stored at −80 °C until the assessment of
total proteins using a modified Lowry method. IL-8 in the
biopsy homogenate supernatant was measured via ELISA
using commercially available assay kits (Research and
Diagnostic Systems, Minneapolis, Minnesota, USA). The
assays were performed in duplicate according to the man-
ufacturer’s instructions. In our laboratory, the ELISA's
sensitivity for IL-8 was approximately 10 pg/ml.
mtMSI detection
PCR-single-strand conformation polymorphism (PCR-
SSCP) analysis was performed to amplify mtDNA micro-
satellite sequences using published primers [24]. The
primers consisted of 2 D-loop regions and 5 coding re-
gions (Table 1). The reaction conditions and procedures
were similar to those reported by Hebano et al. [24].
Table 1 Primer sequences for PCR analysis
Repeat sequence mtDNA region Position Annealing(°C) Primer(5’-3’)
(C)n 270-425 D-loop 58 TCCACACAGACATCAATAACA
AAAGTGCATACCGCCAAAAG
(CA)n 467-556 D-loop 55 CCCATACTACTAATCTCATCAA
TTTGGTTGGTTCGGGGTATG
(C)6 3529-3617 ND1 55 CCGACCTTAGCTCTCACCAT
AATAGGAGGCCTAGGTTGAG
(A)7 4555-4644 ND2 55 CCTGAGTAGGCCTAGAAATAAA
ACTTGATGGCAGCTTCTGTG
(T)7 9431-9526 C0III 55 CCAAAAAGGCCTTCGATACG
GCTAGGCTGGAGTGGTAAAA
(C)6 and(A)8 12360-12465 ND5 55 CACCCTAACCCTGACTTCC
GGTGGATGCGACAATGGATT
(CCT)3 and(AGC)3 12940-13032 ND5 55 GCCCTTCTAAACGCTAATCC
TCAGGGGTGGAGACCTAATT
Table 2 H. pylori infection in different gastric diseases
n H. pylori+ H. pylori -
Normal mucosa 30 0 30
Chronic gastritis 40 18(45.0) 22(65.0)
Intestinal metaplasia 40 22(55.0) 18(45.0)
Dysplasia 20 9(45.0) 11(55.0)
Gastric cancer 122 52(42.6) 70(57.4)
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ate restriction enzymes and electrophoresed at 300 V
at 22 °C for 2 h in a 7.5 % polyacrylamide gel con-
taining 50 mmol/L boric acid, 1 mmol/L EDTA and
2.5 % glycerol. After silver staining, PCR products
that showed a mobility shift were defined as showing
mtMSI. All analyses were repeated twice to rule out
PCR artifacts.
Statistical analysis
The mucosal level of the IL-8 protein was expressed
in pg/mg biopsy protein, and the data were expressed
as the median and range. Wilcoxon’s matched pairs
test was used to compare differences in IL-8 protein
expression between H. pylori-positive and H. pylori-
negative specimens. The relationship between H. pylori
and the production of IL-8 and mtMSI was assessed
using Spearman’s rank correlation coefficient and the
Chi-square test with Yates’ correction. A P value of less
than 0.05 was accepted as statistically significant.
Results
H. pylori infection in different gastric diseases
As shown in Table 2, the rate of H. pylori infection was
45.0 % in chronic gastritis, 55.0 % in intestinal metapla-
sia, 45.0 % in dysplasia and 42.6 % in gastric cancer. No
H. pylori was detected in normal gastric mucosae. The
rates of H. pylori infection in chronic gastritis, intestinal
metaplasia, dysplasia and gastric cancer were signifi-
cantly higher than in the normal gastric mucosa.
H. pylori infection and IL-8 expression
The IL-8 expression levels associated with different gas-
tric pathologies are shown in Fig. 1. H. pylori infectionwas associated with increased expression of IL-8; the
level of IL-8 was significantly higher in various gastric
mucosae with H. pylori infection than in those without
H. pylori infection (P < 0.01).H. pylori infection and mtMSI
All tumor and non-neoplastic gastric mucosal samples
were screened for mtMSI at seven repeat sites using
the PCR-RFLP method. Fig. 2a shows a representative
mobility-shift band compared with normal counter-
parts. The rates of mtMSI in different gastric patholo-
gies are shown in Fig. 2b. H. pylori infection was
associated with increased mtMSI in various gastric
pathologies, and the rate of mtMSI was significantly
higher in specimens with H. pylori infection than in
those without H. pylori infection (P < 0.01).Expression of IL-8 in gastric mucosae with mtMSI
The relationship between IL-8 expression and mtMSI is
shown in Fig. 3. The levels of IL-8 were significantly
higher in gastric mucosae with mtMSI than in those
without mtMSI (P < 0.05).
Fig. 1 The relationship between H. pylori infection and IL-8 expression. The levels of IL-8 were significantly higher in various gastric mucosae with
H. pylori infection than in those without H. pylori infection (*P < 0.01)
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characteristics of gastric cancer
The relationships between IL-8 levels and the clinico-
pathological characteristics of gastric cancer are shown
in Table 3. Associations between IL-8 levels and inva-
sion, lymph node spreading and clinical staging were
found (P < 0.01), whereas no significant correlation was
found between IL-8 levels and the age at diagnosis, sex
or tumor size (P > 0.05).
Clinicopathological characteristics of mtMSI-positive
gastric cancer
The clinicopathological characteristics of mtMSI-positive
cases were compared with those of cases that were mtMSI
negative (Table 4). Associations of mtMSI with the in-
testinal histological type and a distal location were
found (P < 0.05), whereas no significant correlation was
found between mtMSI and the age at diagnosis, sex,
tumor size, tumor location, invasion, lymph node
spread or clinical stage (P > 0.05).
Discussion
Although a causal relationship exists between H. pylori in-
fection and the development of gastric carcinoma, the mo-
lecular mechanisms underlying this relationship have
remained elusive. In this study, we show that H. pylori in-
fection may correlate with up-regulated IL-8 expression
and mtMSI in the gastric mucosa of patients with various
gastric pathologies. Up-regulation of IL-8 is correlated withmtMSI. These findings are consistent with IL-8 and mtMSI
playing important roles in H. pylori-associated gastric can-
cer. Taking into consideration the increase in the mtMSI
frequency observed in H. pylori-associated lesions, our re-
sults suggest early involvement and continuous accumula-
tion of mtMSI in gastric cells with H. pylori infection that
have entered the multistep gastric carcinogenesis pathway.
Mutations in the mitochondrial genome have been de-
tected in nearly every type of cancer investigated to date
[25], including gastric cancer and the corresponding pre-
neoplastic lesions [26]. H. pylori infection has been re-
ported as an important risk factor for gastric
carcinogenesis [5, 27]. Previous studies have identified a
significant association of H. pylori infection and gastric
cancer with nMSI [24, 28]. Although some studies ad-
dressing mitochondrial mutations in gastric cancer have
attempted to identify the role of mitochondrial genetic
instability [22, 24, 29], reports on the role of H. pylori in
mtMSI in gastric carcinogenesis have been rare. mtDNA
mutations are associated with H. pylori infections re-
sponsible for chronic gastritis and peptic ulcer tissues,
indicating that the consequences of H. pylori infection
include the aggregation of mutations in mtDNA in early
phases of gastric cancer development. Machado et al.
[30] showed that gastric epithelial cells are closely re-
lated to the genetic instability of mitochondrial DNA
due to H. pylori infection. To study the role of mtMSI in
H. pylori-associated gastric carcinogenesis, we analyzed
mtMSI in H. pylori-positive and H. pylori-negative
Fig. 2 The relationship between H. pylori infection and mtMSI. a. Detection of mtMSI via PCR-single strand conformation polymorphism analysis.
Lane 6 shows conformational variants associated with mtMSI. b. The detection rate of mtMSI was significantly higher in specimens with H. pylori
infection than in those without H. pylori infection (*P < 0.05)
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known to be altered in gastrointestinal carcinomas. It
was found that as carcinogenesis progresses, the level of
mtMSI increases, and the rate of mtMSI was found to
be significantly higher in the H. pylori-positive groups
than the H. pylori-negative groups, implying that mtMSI
might play a role in the occurrence of those gastric can-
cers that are H. pylori positive.
The mechanisms underlying mtMSI induced by H.
pylori in the gastric mucosa remain unclear. Reactive
oxygen species (ROS) are commonly released in gastric
mucosae that are inflamed as a result of infection with
H. pylori, especially with CagA+ strains, and could be re-
sponsible for mtMSI-positive gastric cancer [31, 32]. The
mitochondrial genome is particularly susceptible to oxi-
dative damage and mutation because of the high rate of
ROS generation in this organelle and its inefficient DNA
repair system [33, 34]. Increased damage caused by ROS
and defective DNA repair are the two causes that have
been proposed to explain mtMSI in H. pylori-associated
gastric cancer [31, 33]. A significant correlation betweenhigh IL-8 expression in the gastric mucosa and gastric
cancer risk has been reported [35]. In IL-8 transgenic
mice, the expression of IL-8 increases tumorigenesis,
suggesting that IL-8 might play a crucial role in gastro-
intestinal cancers [36]. The induction of higher levels
IL-8 expression by H. pylori has been observed in gastric
carcinoma and premalignant lesions [12]. In the present
study, we found that the levels of IL-8 were significantly
higher in patients with mtMSI than in those without
mtMSI, suggesting that IL-8 may play a role in the de-
velopment of mtMSI induced by H. pylori. However, the
mechanisms through which IL-8 leads to the develop-
ment of mtMSI in H. pylori-positive gastric mucosae
need to be studied further.
Cancers arising from different mutational pathways
are thought to have different clinical features. nMSI+
gastric cancer is characterized by an older age, antral
location, intestinal type, lower prevalence of lymph
node metastasis, and a lower pTNM stage [37, 38].
However, the clinicopathological characteristics of
mtMSI+ gastric cancers remain unclear. In the current
Fig. 3 IL-8 levels in gastric mucosae with mtMSI. The levels of IL-8 were significantly higher in gastric mucosae with mtMSI than in those without
mtMSI (*P < 0.05)
Table 3 Relationships between IL-8 levels and clinicopathological
characteristics of gastric cancer
Characteristic n level of IL-8
Sex Male 88 62.2 ± 3.1
Female 34 58.2 ± 3.2
Age <40 years 39 58.2 ± 3.6
>40 years 83 61.2 ± 3.4
Size <5 cm 62 57.2 ± 3.5
>5 cm 60 63.2 ± 2.9
Histological type
Intestinal 72 64.2 ± 3.3
Diffuse 50 56.2 ± 3.9
Tumor location
Distal 81 57.2 ± 2.8
Proximal 41 63.2 ± 3.5
Invasion
Within the wall 62 48.2 ± 3.1*
Invading serosa 60 72.2 ± 2.7
Lymph node spread
Absent 58 35.2 ± 2.6*
Present 64 76.2 ± 3.1
TNM stage
I/II 53 38.4 ± 3.2*
III/IV 69 74.5 ± 2.9
*P < 0.01 vs. the invading serosa, lymph node spread and stage III/IV groups
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mtMSI and tumor size, the depth of invasion, node
metastasis or clinical stage, indicating a limited role of
mtMSI in predicting the prognosis of gastric carcin-
oma. However, a marked difference in mtMSI was
noted in gastric cancers distinguished by histological
type. mtMSI was significantly more frequent in
intestinal-type gastric cancers than diffuse-type gastric
cancers, suggesting that mtMSI is a predisposing event
in intestinal gastric cancer.
IL-8 can regulate neovascularization, thereby promot-
ing the growth and spread of human gastric carcinoma
[39]. Yamaoka et al. found that the expression of IL-8
was 10 times higher in gastric cancer tissue than in nor-
mal tissue and it was twice as high in advanced gastric
cancer tissue compared with early cancer tissue [15].
Macrì et al. [40] reported that serum levels of IL-8 serve
as a marker of gastric cancer. Increased expression of
IL-8 mRNA in tissue extracts from gastric cancer pa-
tients has been associated with certain clinicopathologi-
cal aspects of the disease, including a poor prognosis
[41]. In a previous study, we showed that co-culture with
H. pylori stimulates AGS cell motility and invasion,
upregulates ezrin expression at the protein level and in-
duces a Hummingbird phenotype [42]. In the present
study, IL-8 levels were found to be associated with inva-
sion, lymph node spreading and clinical stage. These ob-
servations indicate that high levels of IL-8 may be
associated with a poor prognosis and that IL-8 may be
indicative of more aggressive gastric cancer.
Table 4 Clinicopathological characteristics of 122 gastric cancer
patients with mtMSI
Characteristic n mtMSI+ mtMSI-
Age <40 years 39 9 30
>40 years 83 19 64
Sex Male 88 20 68
Female 34 8 18
Size <5 cm 62 11 51
>5 cm 60 17 43
Histological type Intestinal 72 19* 53
Diffuse 50 9 41
Tumor location Distal 81 21 60
Proximal 41 7 34
Invasion Within the wall 62 18 44
Invading serosa 60 10 50
Lymph node spread Absent 58 17 41
Present 64 11 53
TNM stage
I/II 53 13 40
III/IV 69 15 54
*P < 0.05 vs. diffuse-type groups
Ling et al. Infectious Agents and Cancer  (2016) 11:30 Page 7 of 8Conclusion
In conclusion, we have demonstrated that mtMSI is an
early and important event in the progression of gastric car-
cinogenesis, especially in intestinal-type gastric cancer. H.
pylori infection contributes to mtMSI in early steps of gas-
tric cancer development. IL-8 may play a role in the devel-
opment of mtMSI induced by H. pylori. Our results
support a role for mtMSI in different mechanisms of gastric
carcinogenesis. Because the majority of patients with H.
pylori infection will not progress to cancer and only a sub-
set of these patients harbor mtMSI, it is conceivable that
patients with H. pylori infection displaying mtMSI are at
greater risk of developing gastric cancer than those without
instability. As a surrogate marker for the risk of gastric can-
cer development, the role of mtMSI in gastric lesions with
H. pylori infection warrants further investigation.
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